ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIP | AMGN | GILD | VRTX | REGN |
| Company | ANI Pharma Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 66.03 | 270.63 | 66.58 | 404.50 | 906.90 |
| High | 66.19 | 274.86 | 67.19 | 406.83 | 915.70 |
| Low | 65.15 | 269.65 | 66.37 | 399.29 | 904.41 |
| Last | 65.42 | 273.34 | 67.08 | 400.79 | 908.24 |
| Change | -0.72 | -0.20 | +0.05 | -4.12 | +0.92 |
| % Change | -1.09% | -0.07% | +0.07% | -1.02% | +0.10% |
| Volume | 46,626 | 1,290,665 | 5,379,132 | 489,090 | 246,980 |
| 20-Day Average Volume | 145,062 | 2,110,541 | 6,313,115 | 953,150 | 435,013 |
| Previous Close | 66.14 | 273.54 | 67.03 | 404.91 | 907.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 66.86 | 271.58 | 69.06 | 403.35 | 926.38 |
| 20-Day Raw Stochastic | 17.51% | 46.33% | 12.64% | 36.20% | 20.75% |
| 20-Day Relative Strength | 49.26% | 48.75% | 32.46% | 45.72% | 40.17% |
| Weighted Alpha | +61.02 | +11.48 | -21.06 | +16.59 | +14.18 |
| Today's Opinion | 72% Buy | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 40% Sell | 100% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 88% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.32% since 04/17/24 | +3.61% since 04/17/24 | -0.03% since 04/17/24 | +2.27% since 04/17/24 | +0.79% since 04/17/24 |
| Low | 64.20 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 891.46 on 04/19/24 |
| High | 66.90 on 04/23/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -6.19% since 03/22/24 | -0.93% since 03/22/24 | -7.85% since 03/22/24 | -3.28% since 03/22/24 | -6.09% since 03/22/24 |
| Low | 64.20 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 70.81 on 03/25/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +18.24% since 01/24/24 | -10.44% since 01/24/24 | -15.87% since 01/24/24 | -5.97% since 01/24/24 | -4.21% since 01/24/24 |
| Low | 53.69 on 01/29/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 70.81 on 03/25/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +12.38% since 10/24/23 | -0.91% since 10/24/23 | -14.39% since 10/24/23 | +8.84% since 10/24/23 | +12.94% since 10/24/23 |
| Low | 48.20 on 12/08/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 70.81 on 03/25/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,394,165 | 146,720,288 | 83,457,512 | 104,652,640 | 99,589,264 |
| Shares Outstanding, K | 21,079 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 486,820,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | 18,780,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 131,650,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | 1,160,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 0.79 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.00 on 02/29/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 17.00 | 14.58 | 9.96 | 29.76 | 23.95 |